CStone Pharmaceuticals (HKG:2616)

CStone Pharmaceuticals Revenue

CStone Pharmaceuticals had revenue of 205.10M CNY in the half year ending June 30, 2026, a decrease of -19.30%. This brings the company's total for the last twelve months to 425.23M, up 110.00% year-over-year. In the year 2025, CStone Pharmaceuticals had annual revenue of 269.58M, down -33.80%. That makes CStone Pharmaceuticals the 26,257th largest company in the world by revenue and 1,557th in Hong Kong.

• Revenue (ttm): 425.23M CNY
• Revenue Growth: +110.00%
• P/S Ratio: 16.49
• Revenue / Employee: 2.89M CNY
• Employees: 147
• Market Cap: 8.02B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Outside Mainland China 185.74M 68.9%
• Mainland China 83.84M 31.1%

Fiscal year ended Dec 31, 2025 See the full CStone Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	269.58M	-137.62M	-33.80%
Dec 31, 2024	407.21M	-56.64M	-12.21%
Dec 31, 2023	463.84M	-17.52M	-3.64%
Dec 31, 2022	481.36M	237.65M	97.51%
Dec 31, 2021	243.72M	-795.11M	-76.54%

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error